The Fellow on Call: The Heme/Onc Podcast Episode 122: AML Series, Pt 8 - AML Maintenance Therapies
Nov 13, 2024
This discussion highlights cutting-edge maintenance therapies for acute myeloid leukemia (AML). It reviews the role of cytarabine consolidation and the significance of hypomethylating agents in restoring gene function. Personal anecdotes enrich insights on the treatment journey of patients. Challenges surrounding targeted therapies, especially FLT3 inhibitors, are explored alongside the promising drug giltaritinib. The importance of evaluating clinical trial data to enhance patient outcomes is emphasized, making for a comprehensive overview of AML therapies.
Chapters
Transcript
Episode notes